top of page
A story of innovation, passion and medical value continues
It has been a privilege and a pleasure to support nearly all of Andreas’s innovations over the past 15 years. The journey from the early days of innovation to today's MultiClot system is not only a testament to technological excellence but also to the persistence of a vision rooted in clinical relevance and collaboration. This new platform represents more than just technical progress—it reflects the collective wisdom of decades of development, multidisciplinary input, and fro
violetajardin
Aug 4, 20251 min read
TGA approval: Apiro consumables for ClotPro – ready for MultiClot
Haemoview Diagnostics is pleased to announce TGA approval for Apiro consumables for use on ClotPro analysers in Australia, giving laboratories and clinical teams a compliant pathway to adopt the new consumables range on their existing platform. A smooth transition for current users The approved Apiro consumables are compatible with current ClotPro devices, allowing existing users to continue testing on their installed analysers without changing hardware.This creates a practic
violetajardin
Apr 81 min read
Why a tPA challenge test is clinically essential.
Is your ICU currently assessing fibrinolytic capacity in sepsis and DIC patients? New research just published in Intensive Care Medicine confirms what functional fibrinolysis testing has been telling us — and why a tPA challenge test is clinically essential. Tschirhart et al. (2026) demonstrate that sepsis-induced DIC is characterised by a marked depletion of functional plasminogen, driven by neutrophil elastase–NET complexes that fragment plasminogen into inactive forms. The
violetajardin
Mar 161 min read
DOASENSE in Acute Stroke: Why Point-of-Care DOAC Testing Is Changing the Game
The Challenge For patients presenting with acute ischaemic stroke, time is brain. The decision to administer thrombolysis must be made within a narrow window — and for patients taking direct oral anticoagulants (DOACs), that decision has historically been complicated by one critical question: how much anticoagulant is on board right now? Standard laboratory DOAC plasma testing takes 45–60 minutes — often too slow to inform a timely thrombolysis decision. As a result, many cl
violetajardin
Mar 102 min read
Enhancing Antiplatelet Management in Carotid Artery Stenting with Impedance Aggregometry - Multiplate® Analysis
A recent retrospective study in Clinics and Practice highlights a key challenge in carotid artery stenting (CAS): many patients on standard dual antiplatelet therapy exhibit high on-treatment platelet reactivity (HTPR) — meaning the medication isn’t adequately inhibiting platelet activity, a risk factor for post-procedural thrombotic events. What’s especially insightful is the role of Multiplate® platelet function analysis in identifying this issue. The study found: ✔️ ~31% o
violetajardin
Mar 101 min read
Clinical insights, product updates, and the latest thinking in coagulation diagnostics from the Haemoview team.
bottom of page